What is the initial approach to treating hyponatremia (low sodium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Approach to Treating Hyponatremia

The initial approach to treating hyponatremia should be based on determining the patient's volume status, severity of symptoms, and the underlying cause, with fluid restriction (<1 L/day) as first-line treatment for mild to moderate euvolemic and hypervolemic hyponatremia. 1

Assessment and Classification

First, classify the patient's hyponatremia based on:

  1. Severity:

    • Mild: 130-134 mmol/L
    • Moderate: 125-129 mmol/L
    • Severe: <125 mmol/L 1, 2
  2. Volume status:

    • Hypovolemic (decreased extracellular fluid)
    • Euvolemic (normal extracellular fluid)
    • Hypervolemic (increased extracellular fluid) 1, 3
  3. Symptom severity:

    • Mild: nausea, headache, weakness
    • Severe: seizures, coma, respiratory distress 2

Treatment Algorithm by Volume Status

1. Hypovolemic Hyponatremia

  • Cause: Excessive diuretic use, dehydration, third-spacing
  • Initial approach:
    • Discontinue diuretics if applicable 4
    • Administer isotonic (0.9%) saline for volume expansion 4, 1
    • Correct underlying cause of fluid loss 3

2. Euvolemic Hyponatremia (SIADH)

  • Cause: SIADH, hypothyroidism, adrenal insufficiency
  • Initial approach:
    • Fluid restriction (1-1.5 L/day) 4, 1
    • Ensure adequate solute intake (salt and protein) 5
    • Address underlying cause (e.g., medications, malignancy) 2

3. Hypervolemic Hyponatremia

  • Cause: Heart failure, cirrhosis, nephrotic syndrome
  • Initial approach:
    • Fluid restriction (1-1.5 L/day) 4, 1
    • Sodium restriction (5-6.5 g/day or 87-113 mmol/day) 1
    • Diuretic therapy (spironolactone and furosemide) 4, 1

Treatment Based on Symptom Severity

Asymptomatic or Mildly Symptomatic (Serum Na 126-135 mmol/L)

  • Continue diuretic therapy if needed but monitor electrolytes closely
  • No water restriction necessary 4
  • Treat underlying cause 2

Moderately Symptomatic (Serum Na 121-125 mmol/L)

  • Consider stopping diuretics 4
  • Implement fluid restriction (1-1.5 L/day) 4
  • Monitor serum sodium levels closely 4

Severely Symptomatic (Serum Na <120 mmol/L or neurological symptoms)

  • Stop diuretics immediately 4
  • For seizures, coma, or cardiorespiratory distress:
    • Administer 3% hypertonic saline (100-150 mL bolus or infusion) 1, 5
    • Target initial correction of 4-6 mEq/L in first 1-2 hours 2
    • Limit correction to maximum 8-10 mEq/L in 24 hours to prevent osmotic demyelination syndrome 1, 2

Important Cautions

  • Avoid overcorrection: Never correct serum sodium by >8-10 mEq/L in 24 hours to prevent central pontine myelinolysis 1, 6
  • Frequent monitoring: Check serum sodium levels every 2-4 hours during active correction 5
  • Recognize limitations: Fluid restriction alone is often insufficient as monotherapy, especially in hypervolemic states 1
  • Avoid indiscriminate use: Hypertonic saline can worsen ascites and edema in hypervolemic states 1

Second-Line Therapies

If initial therapy fails to correct hyponatremia:

  • Vasopressin receptor antagonists (vaptans): Consider for euvolemic or hypervolemic hyponatremia 1, 7

    • Tolvaptan has shown efficacy in increasing serum sodium in 45-82% of cirrhotic patients 1, 7
  • Urea: Effective and safe second-line treatment for SIADH 5

  • Demeclocycline or lithium: Alternative options for SIADH 4

By following this structured approach based on volume status and symptom severity, clinicians can effectively manage hyponatremia while minimizing risks of complications from either the condition itself or its treatment.

References

Guideline

Hyponatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.